Insider Selling: Plexus (NASDAQ:PLXS) CEO Sells $358,740.00 in Stock

Plexus Corp. (NASDAQ:PLXS) CEO Todd Kelsey sold 1,500 shares of Plexus stock in a transaction on Wednesday, October 21st. The stock was sold at an average price of $239.16, for a total value of $358,740.00. Following the completion of the sale, the chief executive officer directly owned 62,888 shares of the company’s stock, valued at approximately $15,040,294.08. The trade was a 2.33% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Plexus Stock Performance

Shares of NASDAQ:PLXS traded down $17.93 during midday trading on Thursday, reaching $220.78. 439,666 shares of the company’s stock traded hands, compared to its average volume of 310,960. Plexus Corp. has a one year low of $132.03 and a one year high of $307.06. The stock has a 50 day moving average of $251.49 and a 200 day moving average of $258.52. The company has a market cap of $5.91 billion, a price-to-earnings ratio of 32.56 and a beta of 0.88. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.72 and a current ratio of 1.49.

Plexus (NASDAQ:PLXS) last issued its earnings results on Wednesday, July 29th. The technology company reported $2.32 earnings per share for the quarter, topping analysts’ consensus estimates of $2.13 by $0.19. The business had revenue of $1.30 billion during the quarter, compared to analyst estimates of $1.23 billion. Plexus had a return on equity of 12.46% and a net margin of 4.03%. Plexus’s revenue was up 28.2% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.64 EPS. Plexus has set its Q4 2026 guidance at 2.470-2.630 EPS. As a group, equities research analysts anticipate that Plexus Corp. will post 7.13 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on the company. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Needham & Company LLC restated a “buy” rating and set a $310.00 price target on shares of Plexus in a research note on Friday, August 14th. Weiss Ratings raised shares of Plexus from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Thursday, October 8th. Sidoti upgraded shares of Plexus from a “neutral” rating to a “buy” rating and set a $308.00 price objective on the stock in a research note on Friday, July 31st. Finally, KeyCorp upgraded shares of Plexus from a “sector weight” rating to an “overweight” rating and set a $300.00 price objective on the stock in a research note on Monday, September 21st. One research analyst has rated the stock with a Strong Buy rating and seven have assigned a Buy rating to the company. According to MarketBeat, the stock presently has an average rating of “Buy” and a consensus target price of $276.86.

Institutional Investors Weigh In On Plexus

A number of institutional investors and hedge funds have recently added to or reduced their stakes in PLXS. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Plexus in the second quarter worth approximately $32,000. Root Financial Partners LLC purchased a new stake in shares of Plexus in the third quarter worth $32,000. Kilter Group LLC purchased a new stake in shares of Plexus in the second quarter worth $40,000. Integrated Wealth Concepts LLC bought a new stake in shares of Plexus during the 2nd quarter valued at $51,000. Finally, Pension & Wealth Management Advisors Inc. bought a new stake in shares of Plexus during the 3rd quarter valued at $45,000. Institutional investors own 94.45% of the company’s stock.

Plexus Company Profile

Plexus Corp. is an electronics manufacturing services company that helps customers design, develop, manufacture and service complex electronic products. The company provides an integrated product-realization process spanning engineering and design, supply-chain management, manufacturing, testing, logistics and aftermarket services.

Plexus supports original equipment manufacturers in industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.